Eli Lilly and Company (NYSE:LLY) Receives Consensus Rating of “Moderate Buy” from Analysts
Eli Lilly and Company (NYSE:LLY – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seventeen have assigned a buy recommendation to […]
Eli Lilly and Company (NYSE:LLY – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seventeen have assigned a buy recommendation to […]
